AI-generated summary
The authors report a randomized blind trial of three photobiomodulation protocols to prevent oral and oropharyngeal mucositis in 60 adults receiving chemotherapy and/or stem cell transplantation. They found that allogeneic transplant was associated with a higher likelihood of mucositis, and the authors describe all three protocols as effective and well tolerated. The study is described as preliminary, and the authors say the protocols were effective in preventing and reducing mucositis.
- Participants
- 60
- Who or what was studied
- Adults aged 18 to 74 undergoing chemotherapy and/or hematopoietic stem cell transplantation
- Limits stated in the abstract
- The abstract describes the study as preliminary, and it does not report wavelengths, dosing details or a control group, which limits interpretation of the effectiveness claims.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.